Inequality and Human Genetics
By Richard Hayes,
The New York Times
| 09. 16. 2008
[Letter to the editor]
David Frum correctly acknowledges that income inequality in the United States has been growing steadily and that the use of genetic technology by the affluent to enhance the "intelligence, health, beauty and strength" of their offspring would exacerbate this trend. But his suggestion that this challenge could be addressed by somehow ensuring that all have access to such technology is woefully misguided. The advent of these technologies would spark a techno-eugenic rat race impossible to constrain absent some system of authoritarian, allocative control. It would fundamentally change the way people regard their children and one another and undermine the integrity of the common human nature that sustains all human values, beliefs and institutions. The genetic modification of our children is a practice that conservatives and liberals alike should be able to agree poses far more risks than benefits, and should be taken off the table as an option.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif.
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
